Changes in Trypanosoma cruzi-specific immune responses following treatment: surrogate markers of treatment efficacy

BACKGROUND: As many as 20 million people are living with Trypanosoma cruzi infection in Latin American, yet few receive any treatment. The major limitation in developing and evaluating potential new drugs for their efficacy is the lack of reliable tests to assess parasite burden and elimination. MET...

詳細記述

保存先:
書誌詳細
主要な著者: Laucella, Susana A., Mazliah, Damián Pérez, Bertocchi, Graciela, Alvarez, María G., Cooley, Gretchen, Viotti, Rodolfo, Albareda, María C., Lococo, Bruno, Postan, Miriam, Armenti, Alejandro, Tarleton, Rick L.
フォーマット: Artigo
言語:Inglês
出版事項: 2009
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2805187/
https://ncbi.nlm.nih.gov/pubmed/19877967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/648072
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料